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Abstract
Background: Hypoxia induces the proliferation of pulmonary arterial smooth muscle cell (PASMC) in vivo and
in vitro, and prostacyclin analogues are thought to inhibit the growth of PASMC. Previous studies suggest that
p27kip1, a kind of cyclin-dependent kinase inhibitor, play an important role in the smooth muscle cell proliferation.
However, the mechanism of hypoxia and the subcellular interactions between p27kip1 and prostacyclin analogues
in human pulmonary arterial smooth muscle cell (HPASMC) are not fully understood.
Methods: We investigated the role of p27kip1 in the ability of Beraprost sodium (BPS; a stable prostacyclin
analogue) to inhibit the proliferation of HPASMC during hypoxia. To clarify the biological effects of hypoxic air
exposure and BPS on HPASMC, the cells were cultured in a hypoxic chamber under various oxygen
concentrations (0.1–21%). Thereafter, DNA synthesis was measured as bromodeoxyuridine (BrdU)
incorporation, the cell cycle was analyzed by flow cytometry with propidium iodide staining. The p27kip1 mRNA
and protein expression and it's stability was measured by real-time RT-PCR and Western blotting. Further, we
assessed the role of p27kip1 in HPASMC proliferation using p27kip1 gene knockdown using small interfering RNA
(siRNA) transfection.
Results: Although severe hypoxia (0.1% oxygen) suppressed the proliferation of serum-stimulated HPASMC,
moderate hypoxia (2% oxygen) enhanced proliferation in accordance with enhanced p27kip1 protein degradation,
whereas BPS suppressed HPASMC proliferation under both hypoxic and normoxic conditions by suppressing
p27kip1 degradation with intracellular cAMP-elevation. The 8-bromo-cyclic adenosine monophosphate (8-Br-
cAMP), a cAMP analogue, had similar action as BPS in the regulation of p27kip1. Moderate hypoxia did not affect
the stability of p27kip1 protein expression, but PDGF, known as major hypoxia-induced growth factors, significantly
decreased p27kip1 protein stability. We also demonstrated that BPS and 8-Br-cAMP suppressed HPASMC
proliferation under both hypoxic and normoxic conditions by blocking p27kip1 mRNA degradation. Furthermore,
p27kip1 gene silencing partially attenuated the effects of BPS and partially restored hypoxia-induced proliferation.
Conclusion:  Our study suggests that moderate hypoxia induces HPASMC proliferation, which is partially
dependent of p27kip1 down-regulation probably via the induction of growth factors such as PDGF, and BPS inhibits
both the cell proliferation and p27kip1 mRNA degradation through cAMP pathway.
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Background
Exposure to chronic hypoxia leads to pulmonary hyper-
tension (PH) associated with the structural remodeling of
pulmonary vessels [1-3]. Many pulmonary disorders are
associated with chronic hypoxia, accompanied by pulmo-
nary hypertension and fatal right heart failure resulting
from pulmonary vascular remodeling [4-6]. Prolonged
exposure to hypoxia is associated with cellular and histo-
logical changes in vascular remodeling, and the key path-
ological findings of pulmonary vascular remodeling are
increased wall thickening of pulmonary vessels and the
muscularization of small arteries. Decreased ambient oxy-
gen concentrations in laboratory animals cause similar
pathological changes, including pulmonary smooth mus-
cle hypertrophy and proliferation [7,8]. Furthermore, sev-
eral studies in vitro have also shown that exposure to
hypoxia stimulates pulmonary arterial smooth muscle cell
(PASMC) proliferation, which might be a key component
of pulmonary vascular remodeling [9-12].
Prostacyclin (PGI2) is thought to improve exercise toler-
ance and survival in patients with either primary or sec-
ondary PH through its ability to inhibit the growth of
PASMC [13-15]. TORAY Industries Inc. developed Berap-
rost sodium (BPS), which was the first chemically stable
and orally active PGI2 analogue to increase intracellular
cAMP levels via adenylate cyclase activation [16]. Since
1995, BPS has been used to treat PH and obstructive
peripheral arterial disease [17,18]. The drug mimics the
biological properties of PGI2, such as activating adenylate
cyclase and increasing intracellular cAMP levels, through
activation of the PGI2 receptor. Owing to its chemical
characteristics, BPS is more stable and persistent than nat-
ural PGI2 and has higher affinity for the PGI2 receptor
[19].
The proliferation of PASMC, which causes pulmonary vas-
cular remodeling, requires the cells to enter the cell cycle.
The most important molecular process for cell cycle pro-
gression is retinoblastoma protein phosphorylation by
cyclin-dependent kinase (CDK)-cyclin complexes, and
CDK activities are mainly regulated by CDK inhibitors
[20] such as p27kip1. Other studies have found that the
CDK inhibitor, p27kip1, plays an important role in the
inhibition of CDK activity and in the proliferation of vas-
cular smooth muscle cells [8,21-23]. On the other hand,
Li et al. found that BPS suppresses systemic vascular
smooth muscle proliferation through cAMP signaling via
p27kip1 expression [24]. On the contrary, cell cycle arrest at
late G1  is caused by p27kip1  expression under severe
hypoxia [25-27]. These results support the notion that the
oxygen-dependent checkpoint of the cell cycle is control-
led by p27kip1 expression, and that cAMP signaling also
interferes with the cell cycle and p27kip1 expression. How-
ever, the precise mechanisms and interactions between
the pathways activated by hypoxia, as well as the antipro-
liferative effects of p27kip1 during exposure to BPS in pul-
monary arterial smooth muscle cells remain uncertain.
We aimed to clarify the inhibitory effect of BPS in cultured
human pulmonary arterial smooth muscle cells
(HPASMC), as well as interactions of the CDK inhibitor
p27kip1. We assessed the effects of BPS and 8-bromo-cyclic
adenosine monophosphate (8-Br-cAMP), a cAMP ana-
logue, on cell proliferation and p27kip1 expression, and
examined the role of p27kip1 in HPASMC proliferation
using p27kip1 gene silencing.
Methods
Reagents
We obtained reagents and materials from various sources
as follows: Humedia SG medium, recombinant human
EGF and FGF, gentamycin, streptomycin, and amphoter-
icin B (Kurabo Ltd., Osaka, Japan); bromodeoxyuridine
(BrdU) proliferation assay kits (Oncogene™, Cambridge,
MA); low-pH cAMP ELISA kits (R&D Systems, Inc., Min-
neapolis, MN); ECL detection system (Amersham, Buck-
inghamshire, UK); Moloney murine leukemia virus
reverse transcriptase (Toyobo Co. Ltd., Osaka, Japan),
Quantitech™ SYBR Green PCR kits (Qiagen, Santa Clarita,
CA); Lipofectamine 2000, 4 – 12% Bis-Tris Nupage gels,
and MES-SDS running buffer (Invitrogen, Carlsbad, CA);
DC protein assay kit and polyvinylidene difluoride
(PVDF) membranes (Bio-Rad Laboratories, Richmond,
CA; rabbit anti-p27kip1 polyclonal antibody, mouse anti-
β-actin monoclonal antibody, horseradish peroxidase-
conjugated goat anti-mouse and rabbit antibody, p27kip1
and control small interfering RNA (siRNA) (Santa Cruz
Biotechnology Inc., Santa Cruz, CA) and BPS was a gift
from Toray Industries Inc. (Tokyo, Japan). All other chem-
icals were purchased from Sigma (St. Louis, MO).
Cell culture
HPASMC supplied by Kurabo Ltd. (Osaka, Japan) were
cultured in Humedia SG medium containing 5% fetal
bovine serum, with 50 µg/ml of gentamycin, 50 ng/ml of
amphotericin B, 1 ng/ml of recombinant human EGF, and
1 ng/ml of recombinant human FGF. The cells were incu-
bated in 75-cm2 tissue culture flasks (Corning, NY, U.S.)
in a cell-culture incubator (37°C, 5% CO2, and 95% air)
and used at the seventh passage after trypsinization in all
experiments. Oxygen concentrations (0.1% ~10%) were
modified using N2-CO2  incubators (BNR-110M; Tabai
ESPEC Corp., Tokyo, Japan; 10-0233, Ikemoto Rika
Kogyo, Co., LTD., Tokyo, Japan).
Incorporation of BrdU into HPASMC
We incubated HPASMC (6,000 cells/cm2) seeded in 96-
well culture plates for 48 h in serum-free DMEM, then
changed the medium to DMEM containing 10% FBS and
antibiotics. Thereafter, the cells were incubated for 24 h inRespiratory Research 2007, 8:77 http://respiratory-research.com/content/8/1/77
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various oxygen concentrations with or without 10 µM
BPS. We measured BrdU incorporation using BrdU prolif-
eration assay kits according to the manufacturer's proto-
col. Briefly, the cells were labeled with 10 ng/ml of BrdU
during the incubation, washed 3 times with cold PBS,
fixed, air dried and incubated with mouse anti-BrdU mon-
oclonal antibody (diluted 1:1,000). The antibody was
aspirated, the cells were washed 3 times and then incu-
bated with peroxidase goat anti-mouse IgG (1:2,000) at
room temperature for 30 minutes. The cells were washed
3 times, and 100 µM substrate was added to each well and
incubated for 10 minutes in darkness. Thereafter, we
measured absorbance at dual-wave lengths of 450 to 540
nm.
Cell cycle and DNA analyses
We examined whether the cell cycle was influenced by the
oxygen concentration using flow cytometry with propid-
ium iodide staining. We incubated HPASMC (6,000 cells/
cm2) seeded in 6-well culture plates for 48 h in serum free
DMEM, then changed the medium to DMEM containing
10% FBS and antibiotics. The cells were further incubated
for 24 h under normal or hypoxic conditions with or with-
out 10 µM BPS. The cells were harvested with trypsin-
EDTA and fixed using 70% ethanol. The ethanol was
removed and the cells were incubated in PBS containing
RNase (172 k units/ml) at 37°C for 30 minutes, stained
with propidium iodide (50 µg/ml) and suspended in PBS
for 30 minutes on ice. DNA fluorescence was measured
and flow cytometry proceeded using an EPICS XL (Beck-
man Coulter, CA).
Assay of intracellular cAMP expression in HPASMC
We incubated HPASMC (6,000 cells/cm2) seeded in 24-
well culture plates for 48 h in serum-free DMEM then
changed the medium to DMEM containing 10% FBS. The
plates were incubated for various periods under normal or
hypoxic conditions in the presence of 10 µM BPS. The
medium was aspirated and adherent cells were solubilized
with 200 µl of 0.1 N HCl and 0.1% Triton X. Thereafter,
cAMP concentrations in the cell lysates were measured
using a low-pH cAMP ELISA kit according to the manufac-
turer's protocol.
Real-time RT-PCR analysis of p27kip1 using LightCycler™
We cultured HPASMC (6,000 cells/cm2) seeded in 6-cm
dishes for 48 h in serum-free DMEM. The cells were
washed twice with PBS, and then placed in DMEM con-
taining 10% FBS and antibiotics under normal or hypoxic
oxygen concentrations for various periods with or without
10 µM BPS or 1 mM of 8-Br-cAMP. The cells were then
harvested by trypsinization, washed 3 times, and pelleted
by centrifugation. Total cellular RNA was obtained by one
acid guanidinium thiocyanate-phenol-chloroform extrac-
tion [28]. Reverse transcription proceeded using 0.5 µg of
total RNA and cDNA was synthesized using 200 U of
Moloney murine leukemia virus reverse transcriptase, 5
µM oligoDT, 1 mM dNTPs, and 3 mM Mg2+ in a total vol-
ume of 20 µl. Annealing proceeded at room temperature
for 5 minutes, extension at 44°C for 40 minutes, and
chain termination at 99°C for 5 minutes.
We then performed PCR using the RT products and spe-
cific oligonucleotide primers for p27kip1 and β-actin. The
sequences of the forward and reverse primers for p27kip1
were 5'-GCCCTCCCCAGTCTCTCTTA-3' and 5'-
TCAAAACTCCCAAGCACCTC-3', respectively, and those
of the forward and reverse primers for β-actin were 5'-
GCAAGCAGGAGTATGACGAG-3' 5'-CAAATAAAGCCAT-
GCCAATC-3', respectively. All PCR reactions proceeded
using a LightCycler™ PCR system (Roche Diagnostics,
Meylan, France) using DNA-binding SYBR green dye to
detect PCR products. The cycling conditions were as fol-
lows: initial denaturation at 95°C for 15 minutes, 50
cycles of denaturation at 94°C for 15 seconds, annealing
at 55°C for 15 seconds, and extension at 72°C for 15 sec-
onds. The β-actin gene served as the reference. The PCR
products were isolated from the LightCycler™ glass capil-
laries, resolved by electrophoresis on 1.5% agarose gels
and confirmed by ethidium bromide (EB) staining. Each
assay was repeated in 6 independent experiments.
Western blot analysis
We cultured HPASMC (6,000 cells/cm2) seeded in 6-cm
dishes for 48 h in serum-free DMEM. The cells were
washed twice with PBS, placed in DMEM containing 10%
FBS and antibiotics and then cultured under normal or
hypoxic oxygen conditions for various periods with or
without 10 µM BPS or 1 mM 8-Br-cAMP. The cells were
then harvested and resuspended in protein lysis buffer
(150 mM of NaCl, 20 mM of Tris-HCl, 1% NP-40, 10 mM
of EDTA, 10% glycerol, 1 mM of PMSF, 10 µg/ml of apro-
tinin, 1 µg/ml of leupeptin, 1 µg/ml of pepstatin) and
incubated for 30 min on ice. Cell lysates were clarified by
centrifugation at 10,000 g for 15 minutes at 4°C, then the
protein content in the supernatants was quantified using
DC protein assay kits. Thereafter, 25 µg of protein per lane
was loaded onto 4 – 12% Bis-Tris Nupage gels with MES
SDS running buffer, according to the manufacturer's pro-
tocol. The gels were transferred to PVDF membranes by
electrophoresis at 100 V for 1 h, then non-specific binding
was blocked in PBS containing 0.2% Tween 20 (PBS-T)
and 5% nonfat milk (blocking buffer) at room tempera-
ture for 1 h. All antibodies were diluted in blocking buffer.
The membrane was then probed with rabbit anti-p27kip1
polyclonal antibody (diluted 1:1,000) or mouse anti-β-
actin monoclonal antibody (diluted 1:5000), and incu-
bated for 1 h at room temperature. Membranes were
washed with PBS-T and incubated with horseradish per-
oxidase-conjugated goat anti-rabbit or mouse IgGRespiratory Research 2007, 8:77 http://respiratory-research.com/content/8/1/77
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(diluted 1:2,000) for 2 h at room temperature. After wash-
ing with PBS-T, proteins were detected using the ECL sys-
tem. Each assay was repeated in 4 independent
experiments.
Analysis of p27kip1 mRNA and protein stability
We cultured HPASMC (6,000 cells/cm2) seeded in 6-cm
dishes for 48 h in serum-free DMEM. The cells were
washed twice with PBS, then placed in DMEM containing
10% FBS and cultured under normal or hypoxic condi-
tions for the indicated periods in the presence of the tran-
scription inhibitor actinomycin D (Act D) (400 nM), or
the protein synthesis inhibitor cycloheximide (CHX) (25
µg/ml), and with or without 10 µM BPS, 1 mM 8-Br-cAMP
or 25 ng/ml of platelet-derived growth factor (PDGF). The
cells were then counted and mRNA and protein stability
was examined per 50,000 cells incubated with Act D and
CHX using RT-PCR and Western blotting, respectively.
Each assay was repeated in 4 independent experiments.
Transfection of siRNA in HPASMC
We incubated HPASMC in 10-cm dishes in DMEM con-
taining 10% FBS for 24 h, until they reached about 60%
confluence. After rinsing, the cells were incubated for 6 h
with serum-free Opti-MEM medium, 5 µl/ml of Lipo-
fectamine 2000, and 50 nM control or p27kip1 siRNA. The
same amount of Opti-MEM medium containing 20% FBS
was added and the cells were incubated for a further for 16
h. At 24 h after transfection, the cells were cultured in
serum-free DMEM for 48 h, harvested and seeded (6,000
cells/cm2) into 6-cm dishes and 96-well culture plates,
then incubated in DMEM supplemented with 10% FBS
and antibiotics for 24 h under normal or hypoxic condi-
tions with or without 10 µM BPS. We then measured BrdU
incorporation into the transfected cells and confirmed tar-
get gene silencing by p27kip1 siRNA using Western blot-
ting.
Statistical analysis
The results are expressed as means ± SE. Statistical analysis
was performed using ANOVA with Bonferroni correction
for multiple comparisons. Comparisons were considered
statistically significant at p < 0.05.
Results
Effects of BPS on HPASMC proliferation during hypoxia
Moderate hypoxia (2% oxygen) promoted, whereas severe
hypoxia (0.1% oxygen) suppressed DNA synthesis in
serum-stimulated HPASMC (Fig. 1a). Under normal and
moderately hypoxic conditions, BPS dose-dependently
suppressed DNA synthesis starting at concentrations of 1
and 10 µM, respectively (Fig. 1b).
Cell cycle visualization by PI staining showed that about
95% of the cells cultured in serum-free DMEM was syn-
chronized at the G0/1 phase and that the cell cycle was
arrested (quiescent state). Moderate hypoxia significantly
promoted cell cycle progression and forced the cells to
enter the S and G2/M phases compared with the control
under normal oxygen conditions and BPS significantly
suppressed the cell cycle progression of cells that were
serum-stimulated under hypoxic conditions (Fig. 2).
Effects of hypoxia and BPS on BrdU incorporation in cultured  HPASMC Figure 1
Effects of hypoxia and BPS on BrdU incorporation in 
cultured HPASMC. Cultured HPASMC were exposed to 
various concentrations of oxygen and BPS in the presence of 
BrdU for 24 hours. (a) Severe hypoxia (0.1% oxygen) sup-
pressed, whereas moderate hypoxia (2% oxygen) significantly 
enhanced BrdU incorporation. *P < 0.05 versus 21% oxygen. 
(b) BrdU incorporation was dose-dependently suppressed by 
BPS under both normoxic and hypoxic conditions. Data are 
expressed as means ± SE (n = 6). Open bars, 21% oxygen; 
solid bars, 2% oxygen. *P < 0.05 versus 21% oxygen control; 
†P < 0.05 versus without BPS.Respiratory Research 2007, 8:77 http://respiratory-research.com/content/8/1/77
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Cell cycle analysis of HPASMC exposed to hypoxia and BPS Figure 2
Cell cycle analysis of HPASMC exposed to hypoxia and BPS. Cultured HPASMC were exposed to 21% and 2% oxygen 
with or without 10 µM BPS for 24 hours. Cells were harvested and DNA fragmentation was analyzed using flow cytometry and 
propidium iodide staining. Area definitions on DNA histograms: C, G0/1 phase; D, S phase; E, G2/M phase. Moderate hypoxia 
(2% oxygen) increased, whereas BPS significantly decreased ratios of S plus G2/M and G2/M phases. Histograms are represent-
ative and bar graph shows data expressed as means ± SE (n = 4). Open bars, ratios of G2/M phases; solid bars, ratios of S plus 
G2/M phases. *P < 0.05 versus 21% oxygen control; †P < 0.05 versus 2% oxygen without BPS.Respiratory Research 2007, 8:77 http://respiratory-research.com/content/8/1/77
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Effects of BPS on cAMP production during hypoxia
Intracellular cAMP production was elevated by 10 µM BPS
from 15 min until 24 h. Intracellular cAMP production
did not significantly differ between ambient and hypoxic
oxygen concentrations (Fig. 3).
Effects of BPS and 8-Br-cAMPon p27kip1 mRNA expression 
during hypoxia
After incubation in serum-depleted medium (quiescent
state), p27kip1 mRNA expression was obviously up-regu-
lated, and decreased by 24 h of serum stimulation. On the
other hand, BPS and 8-Br-cAMP significantly attenuated
the suppression induced by 24 h of serum stimulation.
However, p27kip1 mRNA expression did not significantly
differ between normoxia and moderate hypoxia (Fig. 4a).
To confirm the effect of BPS and hypoxia on p27kip1
mRNA expression, we assessed p27kip1 mRNA stability
using Act D. Both BPS and 8-Br-cAMP significantly sup-
pressed p27kip1 mRNA degradation in cells incubated with
Act D under both normoxic and moderately hypoxic con-
ditions. Although moderate hypoxia did not change
p27kip1 mRNA expression, mRNA stability was slightly
decreased under moderate hypoxia (Fig. 5).
The PCR products were analyzed by agarose gel electro-
phoresis followed by EB staining, which revealed discrete
amplification products of the predicted size (Fig. 4b).
Effects of BPS and 8-Br-cAMP on p27kip1 protein 
expression during hypoxia
A large amount of p27kip1 protein was expressed during
the quiescent state after serum depletion. Serum stimula-
tion significantly decreased p27kip1 protein expression,
which was significantly augmented by moderate hypoxia
for 24 h. In contrast, BPS significantly blocked the reduc-
tion in p27kip1 protein. Incubation with 1 mM 8-Br-cAMP
and BPS similarly affected p27kip1  protein expression
under both normoxic and hypoxic conditions (Fig. 6).
To further understand role of hypoxia and BPS on p27kip1
protein expression, we analyzed the stability of p27kip1
Effects of BPS and 8-Br-cAMPon p27kip1 mRNA expression  during hypoxia Figure 4
Effects of BPS and 8-Br-cAMPon p27kip1 mRNA 
expression during hypoxia. Cultured HPASMC were 
exposed to 21% or 2% oxygen concentrations with or with-
out 10 µM of BPS or 1 mM 8-Br-cAMP for indicated periods. 
Expression of p27kip1 mRNA was measured using Real-time 
RT-PCR using LightCycler™. (a) BPS suppressed p27kip1 
mRNA reduction under both normoxic and hypoxic condi-
tions. Expression of p27kip1 mRNA between normoxic and 
hypoxic conditions did not significantly change. Graph shows 
ratio of p27kip1 to β-actin mRNA expression. Open and solid 
bars, 21% and 2% oxygen, respectively. Data are expressed 
as means ± SE (n = 6). *P < 0.05 versus control. (b) Agarose 
gel electrophoresis with EB staining revealed single amplifica-
tion of predicted PCR products (lane 1, DNA molecular 
weight markers; lane 2, p27kip1; 109 bp; lane 3, β-actin 144 
bp).
Effects of BPS on intracellular cAMP production during  hypoxia Figure 3
Effects of BPS on intracellular cAMP production dur-
ing hypoxia. Cultured HPASMC were exposed to 21% or 
2% oxygen in the presence or absence of 10 µM of BPS for 
indicated periods. Concentrations of cAMP in cell lysates 
were measured using low-pH cAMP ELISA kits. Although BPS 
significantly induced cAMP expression, intracellular cAMP 
expression did not significantly differ between the indicated 
oxygen concentrations. Line with solid circles, 21% oxygen; 
dotted line with open circles, 2% oxygen. Data are expressed 
as means ± SE (n = 6).Respiratory Research 2007, 8:77 http://respiratory-research.com/content/8/1/77
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protein using CHX. Neither BPS nor 8-Br-cAMP altered
p27kip1 protein stability. Moderate hypoxia did not affect
the stability of p27kip1  expression, but decreased the
amount of p27kip1 protein. We examined the effect of
hypoxia-induced growth factors using PDGF, a key growth
factor induced by hypoxia, on p27kip1 protein stability.
Under normoxic conditions, 25 ng/ml of PDGF signifi-
cantly decreased p27kip1 protein stability compared with
the control (Fig. 7).
Effects of hypoxia and BPS on p27kip1 knockdown 
HPASMC proliferation
To understand the role of p27kip1 in terms of the inhibi-
tory effect of BPS on cell proliferation, we examined DNA
synthesis in HPASMC transfected with p27kip1  siRNA
under hypoxia in the presence of 10 µM BPS. Western
blots showed that transfection with p27kip1 siRNA signifi-
cantly suppressed p27kip1 protein expression. Transfection
Effects of BPS and 8-Br-cAMP on p27kip1 protein expression  during hypoxia Figure 6
Effects of BPS and 8-Br-cAMP on p27kip1 protein 
expression during hypoxia. Cultured HPASMC were 
exposed to 21% and 2% oxygen with or without 1 mM of 8-
Br-cAMP or 10 µM of BPS for 24 hours, and then Western 
blotted. Hypoxia decreased p27kip1 protein expression. BPS 
and 8-Br-cAMP each significantly increased p27kip1 protein 
expression under both normoxia and hypoxia. Photomicro-
graphs are representative of 4 similar experiments, and bar 
graphs show density ratios of p27kip1 protein versus those of 
β-actin bands. Open and solid bars, 21% and 2% oxygen, 
respectively. Data are expressed as means ± SE (n = 4). *P < 
0.05 versus 21% oxygen control. †P < 0.05 versus 2% oxygen.
Effect of BPS and 8-Br-cAMP on p27kip1 mRNA stability dur- ing hypoxia Figure 5
Effect of BPS and 8-Br-cAMP on p27kip1 mRNA stabil-
ity during hypoxia. Cultured HPASMC were exposed to 
21% or 2% oxygen concentrations with or without 10 µM of 
BPS or 1 mM 8-Br-cAMP for indicated periods. The p27kip1 
mRNA stability was measured after adding 400 nM of Act D 
using Real-time RT-PCR using LightCycler™. Degradation of 
p27kip1 mRNA was significantly suppressed by BPS and 8-Br-
cAMP under both normoxic and moderately hypoxic condi-
tions, and mRNA stability was slightly decreased by moder-
ate hypoxia. Graphs show % maximal p27kip1 mRNA 
expression. Line with solid circles, 21% oxygen; dotted line 
with open circles, 2% oxygen; line with solid squares, 21% 
oxygen and BPS; line with solid triangles, 21% oxygen and 8-
Br-cAMP; dotted line with open squares, 2% oxygen and BPS; 
dotted line with open triangle, 2% oxygen and 8-Br-cAMP. 
Data are expressed as means ± SE (n = 6). *P < 0.05 versus 
21% oxygen. †P < 0.05 versus oxygen controls.Respiratory Research 2007, 8:77 http://respiratory-research.com/content/8/1/77
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with control siRNA, which has a random sequence, did
not affect p27kip1 protein expression. We found that BPS
increased p27kip1 protein expression and significantly sup-
pressed DNA synthesis in cells transfected with control
siRNA. In contrast, transfection with p27kip1 siRNA signif-
icantly decreased p27kip1  protein expression and pre-
vented the BPS-induced inhibition of DNA synthesis. In
addition, moderate hypoxia significantly promoted DNA
synthesis and reduced p27kip1 protein expression in the
control cells, but not in the cells transfected with p27kip1
siRNA (Fig. 8).
Discussion
We showed here that moderate hypoxia (2% oxygen)
enhanced the proliferation of serum-stimulated HPASMC
in accordance with promoted p27kip1 protein degradation,
probably  via  the induction of growth factors such as
PDGF. We also demonstrated that BPS suppressed
HPASMC proliferation under both hypoxic and normoxic
conditions by blocking p27kip1  mRNA degradation
through an increase in intracellular cAMP. In addition, we
Effects of hypoxia and BPS on BrdU incorporation in cells  transfected with p27kip1 siRNA Figure 8
Effects of hypoxia and BPS on BrdU incorporation in 
cells transfected with p27kip1 siRNA. HPASMC were 
transfected with control or p27kip1 siRNA, then exposed to 
21% and 2% oxygen with or without 10 µM BPS for 24 h. 
Western blot analysis showed that p27kip1 protein expression 
in cells transfected with p27kip1 siRNA was significantly sup-
pressed under all conditions. Photomicrographs are repre-
sentative of 4 similar experiments. Transfection with p27kip1 
siRNA significantly prevented BPS-induced inhibition of DNA 
synthesis. Bar graphs show BrdU incorporation relative to 
21% oxygen control. Open and solid bars, 21% and 2% oxy-
gen, respectively. Data are expressed as means ± SE (n = 6). 
*P < 0.05 versus with 21% oxygen; †P < 0.05 versus without 
BPS.
Effects of BPS, 8-Br-cAMP, hypoxia, and PDGF on p27kip1  protein stability Figure 7
Effects of BPS, 8-Br-cAMP, hypoxia, and PDGF on 
p27kip1 protein stability. Cultured HPASMC were 
exposed to 21% or 2% oxygen with or without 10 µM BPS, 1 
mM 8-Br-cAMP, or 25 ng/ml PDGF and 25 µg/ml of CHX for 
indicated periods and Western blotted. Degradation of 
p27kip1 expression did not significantly change among cells 
exposed to hypoxia, BPS, or 8-Br-cAMP. PDGF promoted 
degradation of p27kip1 protein expression. Graphs show % of 
maximal p27kip1 protein expression. Line with solid circles, 
21% oxygen (control); dotted line with open circles, 2% oxy-
gen (hypoxia); line with solid squares, PDGF; dotted line with 
open triangles, BPS; dotted line with solid triangles, 8-Br-
cAMP. Data are expressed as means ± SE (n = 4). *P < 0.05 
versus 21% oxygen.Respiratory Research 2007, 8:77 http://respiratory-research.com/content/8/1/77
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confirmed using p27kip1 gene silencing that p27kip1 regula-
tion in fact reflects HPASMC proliferation.
Increased levels of growth factors derived from the accu-
mulation of hypoxia-inducible factor 1α (HIF-1α) are
thought to regulate PASMC proliferation under hypoxic
conditions since a partial HIF-1α deficiency decreases
muscularizartion of pulmonary arterioles in animals
exposed to chronic hypoxia [7]. Although HIF-1α regu-
lates various transcriptional genes for angiogenic factors,
severe hypoxia and iron depletion induce cell growth
arrest. Our finding that severe hypoxia (0.1% oxygen)
suppressed nucleotide synthesis is in line with those of
others who incubated several tumor cell lines under
hypoxic conditions or with iron chelators [25,29]. In con-
trast to severe hypoxia, other studies have indicated that
moderate hypoxia (1 – 5% oxygen) enhances the prolifer-
ation of rat and bovine PASMC, airway-smooth muscle
cells, lung fibroblasts and mesangial cells [30-33]. Our
findings that DNA synthesis was increased during moder-
ate hypoxia, and that the HPASMC cell cycle progresses
more quickly under hypoxic than normoxic conditions
were also compatible with previous findings.
The suppressive effect of hypoxia on p27kip1 expression
has been demonstrated in mice with pulmonary hyper-
tension induced by hypoxia [8]. However, the expression
of p27kip1, which blocks the cell cycle at the G0/1 phase, is
regulated via several mechanisms including transcription,
protein degradation and translation [34-36]. The data pre-
sented here indicated that hypoxia minimally promoted
p27kip1 mRNA degradation. Our data also suggested that
the hypoxia-induced down-regulation of p27kip1 was not
apparently mediated by hypoxia per se, but rather
mitogenic factors such as PDGF derived via hypoxia
enhanced p27kip1 protein degradation. We demonstrated
that the decrease of p27kip1 expression during hypoxia was
post-transcriptional regulation from the results of RT-PCR
and western blot analysis. We hypothesized that the dis-
crepancy between the results of p27kip1 protein expression
and protein stability during hypoxia may be explained by
the effect of CHX which could suppress the protein
expression of the hypoxic signal transduction including
hypoxia-induced growth factors, such as PDGF. Our
results that PDGF decreased the stability of p27kip1 is con-
sistent with our hypothesis, and we believe that these
results are consistent with conclusion that p27kip1 down-
regulation mediates hypoxia-induced HPASMC prolifera-
tion. The suppressive effect of PDGF on p27kip1 expression
has been demonstrated using rat aortic vascular smooth
muscle cells [37] and in human saphenous vein smooth
muscle cells [38], and oncogenic Ras induces cell cycle
progression and shortens the half-life of p27kip1 protein
[39]. Since both Ras and PDGF activate mitogen-activated
protein kinase (MAPK), we believe that MAPK activated
through growth factors derived from hypoxia and HIF-1α
enhanced the degradation induced by hypoxia.
Our results showed that HPASMC incubated with BPS
were arrested at the G0/1 phase even under hypoxia, with
p27kip1 elevation being associated with increased intracel-
lular cAMP expression, which was not affected by the oxy-
gen concentration. These results indicated that the BPS-
cAMP pathway functioned even under hypoxic conditions
and that p27kip1 elevation might be a consequence of BPS-
induced intracellular cAMP elevation. To confirm this
hypothesis, we investigated the effects of the cAMP ana-
logue 8-Br-cAMP on p27kip1 expression and of BPS on
DNA synthesis in p27kip1 gene knockdown HPASMC. The
effects of 8-Br-cAMP and BPS on p27kip1 expression were
similar and p27kip1-dependent regulation of proliferation
was confirmed in the p27kip1 knockdown cells. Overex-
pression of p27kip1 in rat PASMC decreased thymidine
uptake and cellular proliferation while p27kip1 knock-out
PASMC from mouse had increased cellular proliferation
compared with p27kip1 wild-type PASMC [22]. As well, Yu
et al. demonstrated that hypoxia decreased p27kip1 expres-
sion in the lung and the anti-proliferative effects of
heparin during hypoxia were absent in p27kip1 knock-out
mouse compared with p27kip1 wild-type mouse [8,23].
Using p27kip1 siRNA, we demonstrated that the anti-pro-
liferative effects of BPS during hypoxia were lessened in
the decrease of p27kip1. Therefore, we consider that our
results from 27kip1 siRNA experiments are consistent with
the published results, and we believe that our results dem-
onstrate the importance of p27kip1 in the hypoxic regula-
tion of PASMC proliferation and hypoxia-induced
pulmonary hypertension and remodeling, which would
add an important additional advancement in this field.
We also found that BPS and 8-Br-cAMP suppressed
p27kip1  mRNA degradation under both normoxic and
hypoxic conditions. Although cAMP regulates the expres-
sion of several genes, and the control of the mRNA degra-
dation rate by cAMP is also an important regulatory
mechanism of gene expression [40-42], the mechanisms
responsible for cAMP-regulated mRNA stability are not as
well understood as those of transcriptional regulation.
Recent findings have suggested that p27kip1 mRNA stabil-
ity is controlled by interactions between MAPK-depend-
ent regulation [43] and Rho-dependent translation [44].
In addition, cAMP induces cell relaxation through Rho
GTPase activation [45,46], which might be an important
target of hypoxic pulmonary vascular remodeling [47,48].
These reports imply that the Rho and MAPK interaction
contributes to p27kip1 mRNA stability during exposure to
agents that elevate cAMP and hypoxia. Therefore, to clarify
the detailed mechanisms of hypoxia and cAMP with
respect to p27kip1  expression, additional studies areRespiratory Research 2007, 8:77 http://respiratory-research.com/content/8/1/77
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required to explain the relationship between cAMP and
Rho.
Conclusion
In summary, we found that BPS and hypoxia play critical
roles in HPASMC growth through p27kip1-cAMP and
hypoxia-induced pathways. We believe that clarification
of the precise mechanisms of pulmonary smooth muscle
proliferation will lead to improved therapeutic strategies
that targets hypoxic pulmonary hypertension and remod-
elling of the pulmonary circulation.
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